Table 3.
Probability of development of de-novo DSA and any post-transplant DSA using unadjusted and propensity score adjusted logistic regression models.
| Risk of de novo DSA |
Risk of any post-transplant DSA |
|||||
|---|---|---|---|---|---|---|
| Odds ratio | 95% CI | p value | Odds ratio | 95% CI | p value | |
| Un-adjusted | ||||||
| Length of hospital stay (each 5 days) | 1.09 | 1.02–1.16 | .010 | 1.08 | 1.02–1.15 | .011 |
| Adjusted | ||||||
| Length of hospital stay (each 5 days) | 1.11 | 1.02–1.21 | .014 | 1.08 | 1.01–1.16 | .028 |
| PS score | 0.27 | 0.02–4.13 | .343 | 1.08 | 0.13–8.68 | .944 |
DSA: Donor specific antibody; PS: Propensity score; 95% CI: 95% confidence interval.